Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized p

Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized p

Item
http://www.wikidata.org/entity/Q33365185
Taxane-containing regimens for metastatic breast cancerIncreased risk of high-grade hemorrhage in cancer patients treated with gemcitabine: a meta-analysis of 20 randomized controlled trialsPhase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experienceA systematic review of gemcitabine and taxanes combination therapy randomized trials for metastatic breast cancer.Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials.Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis.Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancerProgression-free survival as a surrogate endpoint in advanced breast cancerA dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursGemcitabine single or combination chemotherapy in post anthracycline and taxane salvage treatment of metastatic breast cancer: retrospective analysis of 124 patients.Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer.Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial.Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature.Measurement of chemotherapy-induced alopecia-time to change.Gemcitabine-based chemotherapy as a viable option for treatment of advanced breast cancer patients: a meta-analysis and literature review.A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer.
P2860

Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized p

Item
http://www.wikidata.org/entity/Q33365185
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Gemcitabine, epirubicin, and p ...... ter, prospective, randomized p
@ast
Gemcitabine, epirubicin, and p ...... ter, prospective, randomized p
@en
type
label
Gemcitabine, epirubicin, and p ...... ter, prospective, randomized p
@ast
Gemcitabine, epirubicin, and p ...... ter, prospective, randomized p
@en
prefLabel
Gemcitabine, epirubicin, and p ...... ter, prospective, randomized p
@ast
Gemcitabine, epirubicin, and p ...... ter, prospective, randomized p
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Gemcitabine, epirubicin, and p ...... ter, prospective, randomized p
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921